mortality/aging
|
• some mice die in utero
|
digestive/alimentary system
|
• 10% of tumors in the stomach, small intestine, colon, and rectum
|
neoplasm
|
• 49 of 52 mice between 9 and 18 months of age develop tumors (lung cancer, liver cancer, mammary cancer, and gastrointestinal tract tumors)
• tumors exhibit nuclear atypia, desmoplasia, stromal invasion, and/or distant metastasis
• mice develop lung metastasis from lung cancer or mammary cancer
• tumors exhibit telomere elongation, anaphase bridges, and/or lagging chromosomes
|
|
• 10% of tumors in the stomach, small intestine, colon, and rectum
|
|
• 13% of tumors
|
|
• 3% of tumors are eye Harderian gland adenoma
|
|
• 18% of tumors
|
|
• 2% of tumors
|
|
• 7% of tumors
|
|
• 3% of tumors
|
|
• 2% of tumors are leiomyocarcinoma
|
|
• 2% of tumors are undifferentiated sarcoma
|
|
• 2% of tumors
|
|
• 37% of tumors
|
endocrine/exocrine glands
|
• 13% of tumors
|
|
• 3% of tumors are eye Harderian gland adenoma
|
liver/biliary system
|
• 18% of tumors
|
cellular
|
• elongated in tumor cells
|
|
• tumors exhibit anaphase bridges and/or lagging chromosomes, indicating chromosome instability
|
respiratory system
|
• 37% of tumors
|
integument
|
• 13% of tumors
|
|
• 3% of tumors
|


Analysis Tools